FR2327793A1 - Procede de preparation d'un agent de guerison de la leucemie myelogene et nouveau produit ainsi obtenu - Google Patents

Procede de preparation d'un agent de guerison de la leucemie myelogene et nouveau produit ainsi obtenu

Info

Publication number
FR2327793A1
FR2327793A1 FR7631196A FR7631196A FR2327793A1 FR 2327793 A1 FR2327793 A1 FR 2327793A1 FR 7631196 A FR7631196 A FR 7631196A FR 7631196 A FR7631196 A FR 7631196A FR 2327793 A1 FR2327793 A1 FR 2327793A1
Authority
FR
France
Prior art keywords
curing
preparing
agent
new product
myelogenous leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7631196A
Other languages
English (en)
Other versions
FR2327793B1 (fr
Inventor
Katsuhiro Ogasa
Morio Kuboyama
Minoru Saito
Kazuhiro Nagata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of FR2327793A1 publication Critical patent/FR2327793A1/fr
Application granted granted Critical
Publication of FR2327793B1 publication Critical patent/FR2327793B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR7631196A 1975-10-17 1976-10-15 Procede de preparation d'un agent de guerison de la leucemie myelogene et nouveau produit ainsi obtenu Granted FR2327793A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50124435A JPS5251009A (en) 1975-10-17 1975-10-17 Method of producing drug for treating marrow leukemia

Publications (2)

Publication Number Publication Date
FR2327793A1 true FR2327793A1 (fr) 1977-05-13
FR2327793B1 FR2327793B1 (fr) 1980-04-11

Family

ID=14885408

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7631196A Granted FR2327793A1 (fr) 1975-10-17 1976-10-15 Procede de preparation d'un agent de guerison de la leucemie myelogene et nouveau produit ainsi obtenu

Country Status (5)

Country Link
US (1) US4100022A (fr)
JP (1) JPS5251009A (fr)
DE (1) DE2645993A1 (fr)
FR (1) FR2327793A1 (fr)
GB (1) GB1535063A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0573107A2 (fr) * 1992-06-04 1993-12-08 Merck & Co. Inc. Procédé de production de vaccin de virus de Varicella Zoster atténué

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198479A (en) * 1979-03-30 1980-04-15 Merck & Co., Inc. Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
US4599305A (en) * 1984-07-16 1986-07-08 The Regents Of The University Of California Method and composition for detection of human chronic myelogenous leukemia
US6152142A (en) 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
CN103356706B (zh) * 2005-03-31 2016-01-20 斯丹姆涅恩有限公司 促进无疤愈合或改善皮肤外观的美容制剂
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8182840B2 (en) 2005-09-27 2012-05-22 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US20120301444A1 (en) * 2007-09-27 2012-11-29 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
WO2012170905A1 (fr) 2011-06-10 2012-12-13 Tissuetech, Inc. Procédés de traitement de tissus fœtaux de support, produits en poudre à base de tissu fœtal de support et leurs utilisations
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
KR102386411B1 (ko) 2020-06-03 2022-04-15 주식회사 대동 칼날 미세 조절이 가능한 예취장치

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0573107A2 (fr) * 1992-06-04 1993-12-08 Merck & Co. Inc. Procédé de production de vaccin de virus de Varicella Zoster atténué
EP0573107A3 (fr) * 1992-06-04 1995-04-26 Merck & Co Inc Procédé de production de vaccin de virus de Varicella Zoster atténué.
EP1097988A1 (fr) * 1992-06-04 2001-05-09 Merck & Co., Inc. Procédé de culture des cellules dans une monocouche

Also Published As

Publication number Publication date
DE2645993A1 (de) 1977-04-28
DE2645993C2 (fr) 1988-06-23
US4100022A (en) 1978-07-11
GB1535063A (en) 1978-12-06
JPS5251009A (en) 1977-04-23
JPS5330781B2 (fr) 1978-08-29
FR2327793B1 (fr) 1980-04-11

Similar Documents

Publication Publication Date Title
FR2337143A1 (fr) Procede de preparation de n-phosphonomethylglycine et nouveau produit ainsi obtenu
FR2312967A1 (fr) Procede et appareil de formation d'une base de gomme a macher et le produit ainsi obtenu
EG12060A (en) Process for preparing of 2,4-dichloro-4-benzoylureido diphenyl ethers and their use as insecticide
BE856860A (fr) Procede de preparation de derives d'androstan-17-one, produits obtenus et leur utilisation
BE845918A (fr) Procede de preparation d'un concentre proteique et produit obtenu par ce procede
EG12218A (en) Process for preparing of novel diphenyl ethers and their use as insecticides
BE840117A (fr) Procede de preparation d'hydroxybenzaldehydes
FR2327793A1 (fr) Procede de preparation d'un agent de guerison de la leucemie myelogene et nouveau produit ainsi obtenu
BE851950A (fr) Procede de preparation de molybdene 99 et produit obtenu
FR2310994A1 (fr) Procede de preparation et d'obtention de composes aromatiques mononitres
FR2281767A1 (fr) Procede de preparation perfectionne pour preparer le produit de reaction polyvinylpyrrolidone-iode et produit obtenu
BE843129A (fr) Procede de preparation d'amide alpha-hydroxyisobutyrique a partir d'acetone-cyanhydrine et produit ainsi obtenu
BE863512A (fr) Procede de preparation d'hypochlorite de magnesium dibasique et produit obtenu
BE854063A (fr) Procede de preparation de 4,4-isopropylidene-bis (2,6-dibromo)-phenol et produit ainsi obtenu
BE843248A (fr) Procede de preparation de phtalonitrile, et produit obtenu
FR2314916A1 (fr) Procede de preparation d'urethannes aromatiques
FR2319626A1 (fr) Procede de preparation de dinitriles insatures et nouveaux produits ainsi obtenus
BE849494A (fr) Procede de rechapage de bandage pneumatique et produit ainsi obtenu
FR2335479A1 (fr) Procede de preparation de d-mannitol et nouveau produit ainsi obtenu
BE841285A (fr) Procede de preparation d'acetoacetyl-arylamides
BE855548A (fr) Procede de preparation d'acides 1-aminoalcane-1,1-diphosphoniques, et produit ainsi obtenus
BE849560A (fr) Procede de preparation de trimethyl-3,5,5cyclohexene-2dione-1,4, et produit obtenu
BE835600A (fr) Procede de preparation d'un produit de granulation mixte et produit ainsi obtenu
BE848388A (fr) Procede de preparation de monohydrate d'ethercarboxylate et nouveau produit ainsi obtenu,
BE841471A (fr) Procede de preparation d'humulone et produit obtenu

Legal Events

Date Code Title Description
ST Notification of lapse
AR Application made for restoration
BR Restoration of rights